Literature DB >> 1757927

Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis.

F Wolfe1, D J Hawley, M A Cathey.   

Abstract

We studied clinical and health status measures in 561 patients with rheumatoid arthritis (RA). Two hundred sixty-four patients were seen within 2 years of disease onset and followed for an additional 2 years. Four other groups were each followed for 5 years, and had disease durations of 2-7, 7-12, 12-17, and 17-22 years, respectively, at the first clinic visit. Functional disability developed very early in the course of RA and continued to worsen at about an equal rate over 22 years. Anxiety, pain scores, and self-assessed severity also increased with time, but erythrocyte sedimentation rate (ESR), morning stiffness, and joint counts were unchanged. Treatment resulted in reduction in joint counts and in nonsignificant improvements in ESR, stiffness, and psychological scores. But functional loss increased in each time period in spite of treatment. Variables most effective in controlled clinical trials are not effective as longterm measures of RA outcome.

Entities:  

Mesh:

Year:  1991        PMID: 1757927

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ.

Authors:  S Ziebland; R Fitzpatrick; C Jenkinson; A Mowat; A Mowat
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  Predictors of functional status in patients with early rheumatoid arthritis.

Authors:  L M Jansen; D van Schaardenburg; I E van Der Horst-Bruinsma; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  Efficacy and Toxicity Profile of Methotrexate Chloroquine Combination in Treatment of Active Rheumatoid Arthritis.

Authors:  V K Singal; V P Chaturvedi; K S Brar
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.

Authors:  E Lindqvist; T Saxne; P Geborek; K Eberhardt
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

5.  Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis.

Authors:  Anne Morris; Edward H Yelin; Pantelis Panopalis; Laura Julian; Patricia P Katz
Journal:  J Health Psychol       Date:  2011-03-18

6.  Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population.

Authors:  G Haugeberg; R E Ørstavik; T Uhlig; J A Falch; J I Halse; T K Kvien
Journal:  Osteoporos Int       Date:  2003-04-16       Impact factor: 4.507

7.  Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; M Arkela-Kautiainen; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

8.  Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study.

Authors:  R Munro; R Hampson; A McEntegart; E A Thomson; R Madhok; H Capell
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

9.  Functional ability, social support, and depression in rheumatoid arthritis.

Authors:  D M Doeglas; Th P B M Suurmeijer; W J A van den Heuvel; B Krol; M H van Rijswijk; M A van Leeuwen; R Sanderman
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

Review 10.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.